The Liver Meeting 2021
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Contains (52)
NAFLD Debrief
Part I: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
Promoting Diversity within Hepatology Practice and Research: Domestic and International Considerations
Inflammation and Cell Death in ALD
Clinical Hepatology Debrief
Part II: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
The State of Modern Hepatology in the Americas
Cross-Platform Analyses of Human Biopsies Provide Insights into the Liver-based Immune Responses
Basic Science Debrief
Part III: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
COVID-19 in 2021: Hepatic Outcomes, Clinical Practice and Vaccine Updates
Using Single Cell Genomics Approaches to Decode Human Liver Disease
Hepatitis Debrief
Live Q&A: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
Tailoring NASH Therapy
Tiny Yet Powerful Microbes and Their Potential for Treatment of Liver Diseases
Topline Clinical Research: What this Means for Patients
General Hepatology Update
HBV Global Symposium
The Dance of a Cirrhotic Patient: Multidisciplinary Team Approach
Autoimmune Liver Disease in the Pediatric Patient
A Summary of New Recommendations for Noninvasive Liver Disease Assessment, Malnutrition, Nutrition, Sarcopenia & Frailty, Wilson Disease, Primary Sclerosing Cholangitis-Cholangiocarcinoma, and Palliative Care & End-St
Communications and Social Media in Hepatology
Part I - Increased-risk Organs
Part II - Living Donor, Split Liver: Expanding the Donor Pool
Value-based Medicine in Hepatology
Key Management Updates on Reproductive Health in Chronic Liver Disease (CLD) and Strategies to Improve Sex Disparities in Liver Transplant
Disease Burden and Disparities of Alcohol-associated Liver Disease (ALD) in Special Populations
Advances in Management of Liver Masses
Overlap Syndromes: A Special Interest Group Update
Common Challenges in Clinical Hepatology and Liver Transplant Practice
Expanding HBV Treatment Criteria, New Biomarkers and Cure Updates
Optimal HCV Treatment Approaches to Achieve Elimination
Advances in Molecular Therapies and Emerging Treatment in Advanced HCC
Blood Coagulation in Drug-Induced Liver Injury-Basic Mechanisms and Clinical Applications
Gut-Liver Interaction on Liver Disease
Multidisciplinary Perspectives in Developing New Treatments for NASH Fibrosis
Evaluating Disparities in Access to and Outcomes of Liver Transplantation
Precision Medicine in Evaluation and Treatment of NAFLD
Part I - ACLF: Definitions, Precipitants, and Management of Renal Failure
Part II - Management of Acute-on-Chronic Liver Failure in Adults and Children
Behavioral Health Services: An Unmet Critical Need for Chronic Liver Diseases (CLD)
Controversies in the Screening and Prevention of Clinically Significant Portal Hypertension
Career Development Workshop
Part I - Basics of Navigating Artificial Intelligence in Liver Research
Part II - Basics of Navigating Artificial Intelligence in Liver Research
Clinical Challenges and Practical Solutions at the Interface of Liver Disease and Endoscopy
Contemporary Considerations and Controversies in Liver Transplantation
AASLD/Japan Society of Hepatology Joint Symposium
Presidential Welcome and President's Choice Lecture
Are We Any Closer?
Academic Debates
Powered By